Submit Deal

MALLINCKRODT PLC

HQ - Staines-upon-Thames

Summary

Mallinckrodt Pharmaceuticals is an American-Irish domiciled manufacturer of specialty pharmaceuticals, generic drugs and imaging agents.

Deals Overview

Total Deals8

Valued Deals7

Total Value£ 9.93 B

Avg. Deal Size£ 1.42 B

Market Context

Senior Management

Mark Trudeau
President and CEO
Siggi Olafsson
CEO
Bryan Reasons
CFO

Sort

daniel j. speciale

Vice President at MALLINCKRODT PLC

Manager

Deals

£ 1.10 B

Total Value

mark trudeau

President and CEO at MALLINCKRODT PLC

Manager

Deals

£ 3.51 B

Total Value

john moten

Vice President, Investor Relations at MALLINCKRODT PLC

Manager

Deal

£ 1.54 B

Total Value

bryan reasons

CFO at MALLINCKRODT PLC

Manager

Deal

£ 722 M

Total Value

steven romano

Chief Scientific Officer and Executive Vice President at MALLINCKRODT PLC

Manager

Deal

£ 898 M

Total Value

coleman n. lannum

Senior Vice President, Investor Strategy and IRO at MALLINCKRODT PLC

Manager

Deals

£ 3.31 B

Total Value

rhonda sciarra

Communications Manager at MALLINCKRODT PLC

Manager

Deals

£ 3.31 B

Total Value

meredith fischer

Senior Vice President, Communications and Public Affairs at MALLINCKRODT PLC

Manager

Deals

£ 3.31 B

Total Value

siggi olafsson

CEO at MALLINCKRODT PLC

Manager

Deals

£ 5.90 B

Total Value

derek naten

Vice President, Government Affairs at MALLINCKRODT PLC

Manager

Deals

£ 5.90 B

Total Value

derek belz

Vice President of Investor Relations at MALLINCKRODT PLC

Manager

Deals

£ 5.90 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy